As your body begins burning stored fat for fuel, you may notice mild fatigue until your metabolism stabilizes
This study excluded patients with diabetes to see an affect only on healthy humans
But, what makes tirzepatide different is its the first combination of 2 classes of medications, the GIP and GLP-1 receptor agonist which are both incretin hormones that are released after food intake
These symptoms may indicate fluid retention, declining kidney function, or severe dehydration requiring immediate evaluation
A: Yes, we evaluate each patient individually and, if appropriate, may prescribe weight loss medications as part of your plan
Retatrutide is expected to follow the same in-use limit